Glioblastoma is a highly aggressive primary brain tumour with limited treatment options. Dysregulation of the phosphoinositide 3-kinase (PI3K)/Akt/mechanistic target of rapamycin (mTOR) signalling ...
The PI3K/AKT/mTOR cascade is a central regulator of cell growth, metabolism and survival in gastric epithelial cells. Activation begins with PI3K‐mediated production of ...
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...
BLU-222, an investigational, oral, potent, and highly selective CDK2 inhibitor (CDK2i), as monotherapy in patients (pts) with advanced solid tumors and in combination with ribociclib (RIBO) and ...
Metabolism has always been a crucial pillar in cancer treatment, but clinical considerations have been limited to general diet and nutrition advice, minimizing the potential therapeutic impact of ...
Clinical Milestone Expands Development of Paxalisib Beyond Oncology and Triggers $2 Million Payment to Kazia FCD T2 and TSC are rare, genetically driven neurological disorders in which somatic ...
近日，浙江大学医学院附属第一医院李兰娟/朱丹华团队在国际知名期刊《Signal Transduction and Targeted Therapy》（IF：81.2）发表了一篇题为“PI3K/AKT signaling pathway: molecular crossroads in tumorigenesis and therapeutic innovation”的重磅综述：系统性地揭示了PI3 ...
Erica L. Mayer, MD, MPH, of Dana-Farber Cancer Institute, reviews the rationale for capivasertib in hormone receptor positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast ...
Prognostic value of hedgehog signaling in cervical carcinoma. Background: Although improvements in the treatment of ovarian cancer have increased the global prognosis, the metastatic disease is still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results